Global Cell-Free RNA Isolation and Extraction Market.pdf

1
All rights reserved at BIS Research Inc.
G
L
O
B
A
L
C
E
L
L
-
F
R
E
E
R
N
A
I
S
O
L
A
T
I
O
N
A
N
D
E
X
T
R
A
C
T
I
O
N
K
I
T
S
M
A
R
K
E
T
res
Focus on Application, End User,
and Region
Analysis and Forecast: 2022-2032
August 2022
Cell-Free RNA
Isolation and
Extraction Kits
Market -
A Global and
Regional Analysis
Table of Content

2
G
L
O
B
A
L
C
E
L
L
-
F
R
E
E
R
N
A
I
S
O
L
A
T
I
O
N
A
N
D
E
X
T
R
A
C
T
I
O
N
K
I
T
S
M
A
R
K
E
T
BIS Research is a leading market intelligence and technology research company. BIS Research publishes in-
depth market intelligence reports focusing on market estimations, technology analysis, emerging high-growth
applications, deeply segmented granular country-level market data, and other important market parameters
useful in the strategic decision-making for senior management. BIS Research provides multi-client reports,
company profiles, databases, and custom research services.
Copyright © 2022 BIS Research Inc.
All Rights Reserved. This document contains highly confidential information and is the sole property of BIS
Research. Disclosing, copying, circulating, quoting, or otherwise reproducing any or all contents of this
document is strictly prohibited. Access to this information is provided exclusively for the benefit of the people
or organization concerned. It may not be accessed by or offered, whether for sale or otherwise, to any third
party.

3
G
L
O
B
A
L
C
E
L
L
-
F
R
E
E
R
N
A
I
S
O
L
A
T
I
O
N
A
N
D
E
X
T
R
A
C
T
I
O
N
K
I
T
S
M
A
R
K
E
T
Table of Content
Executive Summary..........................................................................16
1. Markets .....................................................................................21
1.1 Product Definition............................................................................................22
1.1.1 Inclusion and Exclusion Criteria................................................................22
1.2 Market Scope ...................................................................................................22
1.2.1 Scope of the Study......................................................................................22
1.2.2 Key Questions Answered in the Report ....................................................23
1.3 Research Methodology ...................................................................................24
1.3.1 Global cell-free RNA isolation and extraction kits market: Research
Methodology ................................................................................................24
1.3.2 Data Sources ...............................................................................................25
1.3.2.1 Primary Data Sources........................................................................................ 25
1.3.2.2 Secondary Data Sources................................................................................... 25
1.3.3 Market Estimation Model ............................................................................26
1.3.4 Criteria for Company Profiling ...................................................................28
1.4 Market Overview ..............................................................................................28
1.4.1 Introduction: Cell-Free RNA .......................................................................28
1.4.2 Emergence of Cell-Free RNA......................................................................29
1.4.3 Spin Column-Based Technology ...............................................................30
1.4.4 Magnetic Bead-Based Technology ............................................................31
1.4.5 Market Size and Growth Potential, $Million, 2021-2032 ...........................31
1.5 Patent Landscape............................................................................................32
1.5.1 Patent Filing Trend......................................................................................32
1.5.2 Patent Analysis (by Year) ...........................................................................33
1.5.3 Patent Analysis (by Country) .....................................................................34
1.5.4 Patent Analysis (by Region) .......................................................................35
2. Industry Analysis .......................................................................36
2.1 Overview...........................................................................................................37

4
G
L
O
B
A
L
C
E
L
L
-
F
R
E
E
R
N
A
I
S
O
L
A
T
I
O
N
A
N
D
E
X
T
R
A
C
T
I
O
N
K
I
T
S
M
A
R
K
E
T
2.2 Regulatory Framework in the U.S. .................................................................37
2.2.1 FDA Regulations..........................................................................................37
2.3 Regulatory Framework in the European Union (EU) ....................................39
2.4 Regulatory Framework in Asia-Pacific ..........................................................40
2.4.1 China ............................................................................................................40
2.4.2 Japan............................................................................................................42
3. Market Dynamics .......................................................................43
3.1 Market Dynamics .............................................................................................44
3.1.1 Overview ......................................................................................................44
3.2 Impact Analysis ...............................................................................................44
3.3 Market Drivers..................................................................................................46
3.3.1 Increasing Incidence of Cancer..................................................................46
3.3.2 Increasing Number of Cases with Prenatal Complications .....................47
3.3.3 Advancement in the RNA Sequencing Technology .................................49
3.4 Market Restraints.............................................................................................50
3.4.1 Lack of Skilled Professionals and Awareness Related to Cell-Free
RNA Methods...............................................................................................50
3.4.2 Ethical, Legal, and Social Issues Associated with Prenatal
Screening.....................................................................................................50
3.5 Market Opportunities.......................................................................................52
3.5.1 Growth in Emerging Nations ......................................................................52
3.5.2 Rising Funding Activities for Cell-Free RNA Biomarkers ........................52
4. Competitive Landscape .............................................................54
4.1 Overview...........................................................................................................55
4.1.1 Corporate Strategies...................................................................................55
4.1.1.1 Synergistic Activities.......................................................................................... 55
4.1.2 Business Strategies ....................................................................................56
4.1.2.1 Product Launches.............................................................................................. 56
4.2 Market Share Analysis ....................................................................................57

5
G
L
O
B
A
L
C
E
L
L
-
F
R
E
E
R
N
A
I
S
O
L
A
T
I
O
N
A
N
D
E
X
T
R
A
C
T
I
O
N
K
I
T
S
M
A
R
K
E
T
4.3 Growth-Share Analysis (by Company) ..........................................................59
5. Application, $Million, 2021-2032.................................................61
5.1 Overview...........................................................................................................62
5.2 Oncology ..........................................................................................................63
5.3 Prenatal Screening (Preeclampsia)................................................................64
5.4 Metabolic Disorders ........................................................................................65
6. End Users, $Million, 2021-2032 ..................................................66
6.1 Overview...........................................................................................................67
6.2 Academic Research Institutions and Laboratories ......................................68
6.3 Hospitals...........................................................................................................69
6.4 Pharmaceutical and Biotechnology Companies...........................................70
6.5 Diagnostic Laboratories..................................................................................71
7. Region, $Million, 2021-2032 .......................................................72
7.1 Overview...........................................................................................................73
7.2 North America..................................................................................................75
7.3 Europe ..............................................................................................................77
7.4 Asia-Pacific (APAC).........................................................................................79
7.5 Latin America...................................................................................................82
7.6 Rest-of-the-World ............................................................................................84
8. Company Profiles......................................................................85
8.1 Overview...........................................................................................................86
8.2 Aline Biosciences............................................................................................87
8.2.1 Company Overview .....................................................................................87
8.2.2 Role of Aline Biosciences in the Global Cell-Free RNA Isolation and
Extraction Kits Market.................................................................................87
8.2.3 Key Competitors of the Company..............................................................88
8.2.4 Analyst Perspective ....................................................................................88
8.3 Apostle Sciences.............................................................................................89

6
G
L
O
B
A
L
C
E
L
L
-
F
R
E
E
R
N
A
I
S
O
L
A
T
I
O
N
A
N
D
E
X
T
R
A
C
T
I
O
N
K
I
T
S
M
A
R
K
E
T
8.3.2 Role of Apostle Sciences in the Global Cell-Free RNA Isolation and
8.4 Danagen-Bioted, S.L........................................................................................91
8.4.2 Role of Danagen-Bioted, S.L. in the Global Cell-Free RNA Isolation
and Extraction Kits Market .........................................................................91
8.5 F. Hoffmann-La Roche Ltd..............................................................................93
8.5.2 Role of F. Hoffmann-La Roche Ltd. in the Global Cell-Free RNA
Isolation and Extraction Kits Market..........................................................93
8.5.3 Key Customers of the Company ................................................................94
8.5.5 Financials.....................................................................................................94
8.6 JBS Science Inc...............................................................................................98
8.6.2 Role of JBS Science Inc. in the Global Cell-Free RNA Isolation and
8.6.4 Corporate Strategies...................................................................................99
8.6.4.1 Synergistic Activities.......................................................................................... 99
8.6.4.1.1 Agreement................................................................................................................ 99
8.7 Norgen Biotek Corp.......................................................................................100

7
G
L
O
B
A
L
C
E
L
L
-
F
R
E
E
R
N
A
I
S
O
L
A
T
I
O
N
A
N
D
E
X
T
R
A
C
T
I
O
N
K
I
T
S
M
A
R
K
E
T
8.7.1 Company Overview ...................................................................................100
8.7.2 Role of Norgen Biotek Corp. in the Global Cell-Free RNA Isolation
and Extraction Kits Market .......................................................................100
8.7.3 Key Customers of the Company ..............................................................101
8.7.4 Key Competitors of the Company............................................................101
8.7.5 Business Strategies ..................................................................................101
8.7.5.1 Product Launch................................................................................................ 101
8.7.6 Analyst Perspective ..................................................................................101
8.8 PerkinElmer, Inc.............................................................................................103
8.8.2 Role of PerkinElmer, Inc. in the Global Cell-Free RNA Isolation and
Extraction Kits Market...............................................................................103
8.8.5 Financials...................................................................................................105
8.8.6 Key Insights about the Financial Health of the Company......................107
8.9 Promega Corporation....................................................................................108
8.9.2 Role of Promega Corporation in the Global Cell-Free RNA Isolation
and Extraction Kits Market .......................................................................108
8.9.4.1 Product Launch................................................................................................ 109
8.10 QIAGEN N.V....................................................................................................110
8.10.2 Role of QIAGEN N.V. in the Global Cell-Free RNA Isolation and

8
G
L
O
B
A
L
C
E
L
L
-
F
R
E
E
R
N
A
I
S
O
L
A
T
I
O
N
A
N
D
E
X
T
R
A
C
T
I
O
N
K
I
T
S
M
A
R
K
E
T
8.10.5 Financials...................................................................................................112
8.10.6 Key Insights About the Financial Health of the Company .....................114
8.10.7.1 Product Launch................................................................................................ 114
8.11 Streck, Inc.......................................................................................................116
8.11.2 Role of Streck, Inc. in the Global Cell-Free RNA Isolation and
8.11.5.1 Product Launch................................................................................................ 117
8.12 Thermo Fisher Scientific Inc.........................................................................118
8.12.2 Role of Thermo Fisher Scientific Inc. in the Global Cell-Free RNA
Isolation and Extraction Kits Market........................................................118
8.12.5 Financials...................................................................................................120
8.12.6 Key Insights About the Financial Health of the Company .....................122
8.13 Takara Bio Inc. ...............................................................................................123
8.13.2 Role of Takara Bio Inc. in the Global Cell-Free RNA Isolation and

9
G
L
O
B
A
L
C
E
L
L
-
F
R
E
E
R
N
A
I
S
O
L
A
T
I
O
N
A
N
D
E
X
T
R
A
C
T
I
O
N
K
I
T
S
M
A
R
K
E
T
8.13.5 Financials...................................................................................................125
8.14 Zymo Research Corporation.........................................................................128
8.14.2 Role of Zymo Research Corporation in the Global Cell-Free RNA
Isolation and Extraction Kits Market........................................................128

10
G
L
O
B
A
L
C
E
L
L
-
F
R
E
E
R
N
A
I
S
O
L
A
T
I
O
N
A
N
D
E
X
T
R
A
C
T
I
O
N
K
I
T
S
M
A
R
K
E
T
List of Figures
Figure 1: Global Cell-Free RNA Isolation and Extraction Kits Market, $Million, 2021 and 2032
Figure 2: Global Cell-Free RNA Isolation and Extraction Kits Market Segmentation
Figure 3: Global Cell-Free RNA Isolation and Extraction Kits Market (by Application), $Million, 2021-2032
Figure 4: Global Cell-Free RNA Isolation and Extraction Kits Market (by End User), $Million, 2021-2032
Figure 5: Global Cell-Free RNA Isolation and Extraction Kits Market (by Region)
Figure 6: Global Cell-Free RNA Isolation and Extraction Kits Market Segmentation
Figure 7: Global Cell-Free RNA Isolation and Extraction Kits Market: Research Methodology
Figure 8: Primary Research Methodology
Figure 9: Bottom-Up Approach (Segment-Wise Analysis)
Figure 10: Top-Down Approach (Segment-Wise Analysis)
Figure 11: Global Cell-Free RNA Isolation and Extraction Kits Market, $Million, 2021-2032
Figure 12: Global Cell-Free RNA Isolation and Extraction Kits Market, Patent Analysis (by Year), January
2019-June 2022
Figure 13: Global Cell-Free RNA Isolation and Extraction Kits Market, Patent Analysis (by Country), January
2019-June 2022
Figure 14: Global Cell-Free RNA Isolation and Extraction Kits Market, Patent Analysis (by Region), January
2019-June 2022
Figure 15: FDA Classification for Medical Devices
Figure 16: Overview of Regulatory Process for Medical Devices in the U.S.
Figure 17: Overview of Regulatory Process in the European Union (EU)
Figure 18: Overview of Regulatory Process for Medical Devices in China
Figure 19: Global Cell-Free RNA Isolation and Extraction Kits Market Dynamics
Figure 20: Global Cancer Incidence, 2017-2021
Figure 21: Maternal Mortality Rate, Region-Wise, 2020
Figure 22: Maternal Mortality Rate in the U.S.
Figure 23: Ethical, Legal, and Social Issues
Figure 24: Funding Scenario in the Global Cell-Free RNA Isolation and Extraction Kits Market, $Million,
January 2019-February 2022
Figure 25: Share of Key Developments, January 2019-February 2022
Figure 26: Share of Product Launches and Upgrades (by Company), January 2019-February 2022

11
G
L
O
B
A
L
C
E
L
L
-
F
R
E
E
R
N
A
I
S
O
L
A
T
I
O
N
A
N
D
E
X
T
R
A
C
T
I
O
N
K
I
T
S
M
A
R
K
E
T
Figure 27: Market Share Analysis of Global Cell-Free RNA Isolation and Extraction Kits Market (by
Company), 2020 and 2021
Figure 28: Growth-Share Analysis for Global Cell-Free RNA Isolation and Extraction Kits Market (by
Company), 2021
Figure 29: Global Cell-Free RNA Isolation and Extraction Kits Market (by Application), $Million, 2021-2032
Figure 30: Global Cell-Free RNA Isolation and Extraction Kits Market (Oncology), $Million, 2021-2032
Figure 31: Global Cell-Free RNA Isolation and Extraction Kits Market (Prenatal Screening), $Million, 2021-
2032
Figure 32: Global Cell-Free RNA Isolation and Extraction Kits Market (Metabolic Disorders), $Million, 2021-
2032
Figure 33: Global Cell-Free RNA Isolation and Extraction Kits Market (by End User), $Million, 2021-2032
Figure 34: Global Cell-Free RNA Isolation and Extraction Kits Market (Academic Research Institutions and
Laboratories), 2021-2032
Figure 35: Global Cell-Free RNA Isolation and Extraction Kits Market (Hospitals), 2021-2032
Figure 36: Global Cell-Free RNA Isolation and Extraction Kits Market (Pharmaceutical and Biotechnology
Companies), $Million, 2021-2032
Figure 37: Global Cell-Free RNA Isolation and Extraction Kits Market (Diagnostic Laboratories), $Million,
2021-2032
Figure 38: Global Cell-Free RNA Isolation and Extraction Kits Market (by Region)
Figure 39: Global Cell-Free RNA Isolation and Extraction Kits Market (by Region), 2021 and 2032
Figure 40: North America Cell-Free RNA Isolation and Extraction Kits Market, $Million, 2021-2032
Figure 41: Europe Cell-Free RNA Isolation and Extraction Kits Market, $Million, 2021-2032
Figure 42: Asia-Pacific Cell-Free RNA Isolation and Extraction kits Market, $Million, 2021-2032
Figure 43: Latin America Cell-Free RNA Isolation and Extraction Kits Market, $Million, 2021-2032
Figure 44: Rest-of-the-World Cell-Free RNA Isolation and Extraction kits Market, $Million, 2021-2032
Figure 45: Total Number of Companies Profiled
Figure 46: Aline Biosciences: Product Portfolio
Figure 47: Apostle Sciences: Product Portfolio
Figure 48: Danagen-Bioted, S.L.: Product Portfolio
Figure 49: F. Hoffmann-La Roche Ltd.: Product Portfolio
Figure 50: F. Hoffmann-La Roche Ltd.: Overall Financials, 2019-2021
Figure 51: F. Hoffmann-La Roche Ltd.: Revenue (by Segment), $Million, 2019-2021
Figure 52: F. Hoffmann-La Roche Ltd.: Revenue (by Region), $Million, 2019-2021
Figure 53: F. Hoffmann-La Roche Ltd.: R&D Expenditure, $Million, 2019-2021

12
G
L
O
B
A
L
C
E
L
L
-
F
R
E
E
R
N
A
I
S
O
L
A
T
I
O
N
A
N
D
E
X
T
R
A
C
T
I
O
N
K
I
T
S
M
A
R
K
E
T
Figure 54: JBS Science Inc.: Product Portfolio
Figure 55: Norgen Biotek Corp.: Product Portfolio
Figure 56: PerkinElmer, Inc.: Product Portfolio
Figure 57: PerkinElmer, Inc.: Overall Financials, $Million, 2019-2021
Figure 58: PerkinElmer, Inc.: Revenue (by Segment), $Million, 2019-2021
Figure 59: PerkinElmer, Inc.: Revenue (by Region), $Million, 2019-2021
Figure 60: PerkinElmer, Inc.: R&D Expenditure, $Million, 2019-2021
Figure 61: Promega Corporation: Product Portfolio
Figure 62: QIAGEN N.V.: Product Portfolio
Figure 63: QIAGEN N.V.: Overall Financials, $Million, 2019-2021
Figure 64: QIAGEN N.V.: Revenue (by Segment), $Million, 2019-2021
Figure 65: QIAGEN N.V.: Revenue (by Region), $Million, 2019-2021
Figure 66: QIAGEN N.V.: R&D Expenditure, $Million, 2019-2021
Figure 67: Streck, Inc.: Product Portfolio
Figure 68: Thermo Fisher Scientific Inc.: Product Portfolio
Figure 69: Thermo Fisher Scientific Inc.: Overall Financials, $Million, 2019-2021
Figure 70: Company Name: Revenue (by Segment), $Million, 2019-2021
Figure 71: Company Name: Revenue (by Region), $Million, 2019-2021
Figure 72: Thermo Fisher Scientific Inc.: R&D Expenditure, $Million, 2019-2021
Figure 73: Takara Bio Inc.: Product Portfolio
Figure 74: Takara Bio Inc.: Overall Financials, 2019-2022
Figure 75: Takara Bio Inc.: Revenue (by Segment), $Million, 2019-2022
Figure 76: Takara Bio Inc.: Revenue (by Region), $Million, 2019-2022
Figure 77: Takara Bio Inc.: R&D Expenditure, $Million, 2019-2022
Figure 78: Zymo Research Corporation: Product Portfolio

13
G
L
O
B
A
L
C
E
L
L
-
F
R
E
E
R
N
A
I
S
O
L
A
T
I
O
N
A
N
D
E
X
T
R
A
C
T
I
O
N
K
I
T
S
M
A
R
K
E
T
List of Tables
Table 1: Impact Analysis of Market Drivers, Restraints, and Opportunities on the Global Cell-Free RNA
Isolation and Extraction Kits Market
Table 2: Different Types of Cell-Free RNA in Serum/Plasma
Table 3: Examples of Spin-Column Technology-Based Cell-Free RNA Isolation and Extraction Kits
Table 4: Examples of Magnetic-Bead Technology Based Cell-Free RNA Isolation and Extraction Kits
Table 5: Likert Scale
Table 6: Impact Analysis of Market Drivers, Restraints, and Opportunities on the Global Cell-Free RNA
Isolation and Extraction Kits Market

14
G
L
O
B
A
L
C
E
L
L
-
F
R
E
E
R
N
A
I
S
O
L
A
T
I
O
N
A
N
D
E
X
T
R
A
C
T
I
O
N
K
I
T
S
M
A
R
K
E
T
BIS Research Offerings:
We are on a mission to harness the potential of disruptive technologies to make businesses thrive in today’s
digital age. We have the vision to be a leading and preferred knowledge partner for corporates and institutions
worldwide and assist them with market intelligence in the area of emerging technologies, advisories, and other
innovative solutions.
Know More Know More
Know More
Know More

15
G
L
O
B
A
L
C
E
L
L
-
F
R
E
E
R
N
A
I
S
O
L
A
T
I
O
N
A
N
D
E
X
T
R
A
C
T
I
O
N
K
I
T
S
M
A
R
K
E
T
Disclaimer
BIS Research Inc. provides valuable market intelligence to an exclusive group of customers in response to
orders. The report is licensed for the customer's internal use only and is subject to restrictions set henceforth.
This document and its contents are confidential and may not be further distributed, published, or reproduced,
in whole or in part, by any medium or in any form for any purpose, without the express written consent of BIS
Research Inc. Customer will not disclose the contents of the report, whether directly in any media or indirectly
through incorporation in a database, marketing list, report or otherwise, or use or permit the use of information
to generate any statistical or other information that is or will be provided to third parties, or voluntarily produce
information in legal proceedings.
Market reports are based on expectations, estimates, and projections as of the date such information is
available. Any recommendation contained in this report may not be suitable for all investors or businesses.
The market conclusions drawn are necessarily based upon a number of estimates and assumptions that, while
considered reasonable by BIS Research Inc. as of the date of such statements, are inherently subject to
market fluctuations and business, economic and competitive uncertainties, and contingencies.
For more details regarding permission, please contact us:
Email: sales@bisresearch.com
Tel: +1 510 404 8135

16
G
L
O
B
A
L
C
E
L
L
-
F
R
E
E
R
N
A
I
S
O
L
A
T
I
O
N
A
N
D
E
X
T
R
A
C
T
I
O
N
K
I
T
S
M
A
R
K
E
T
BIS RESEARCH INC.
39111 Paseo Padre PKWY, Suite 313 Fremont, CA 94538 -1686
E-mail: hello@bisresearch.com | Call Us: +1-510-404-8135
Global Delivery Center
Tower B First Floor, Tapasya Corporate Heights, Greater Noida Expressway,
Sector 126, Noida, U.P., 201303, India
Tel: +91 120 4261540 / 4261544
www.bisresearch.com

Global Cell-Free RNA Isolation and Extraction Market.pdf

Recommended

Recommended

More Related Content

More from BIS Research Inc.

More from BIS Research Inc. (20)

Global Cell-Free RNA Isolation and Extraction Market.pdf